Yoshitaro Shindo

Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)

Tatsuya Ioka, Masashi Kanai, Shogo Kobayashi et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 2022 · 226 citations · Full text

Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer

Taichi Kuwahara, Shoichi Hazama, Nobuaki Suzuki et al. · British Journal of Cancer · 2019 · 118 citations · Full text

A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study)

Shoichi Hazama, Yusuke Nakamura, Hiroaki Tanaka et al. · Journal of Translational Medicine · 2014 · 86 citations · Full text

Combination immunotherapy with 4-1BB activation and PD-1 blockade enhances antitumor efficacy in a mouse model of subcutaneous tumor.

Yoshitaro Shindo, Kiyoshi Yoshimura, Atsuo Kuramasu et al. · PubMed · 2015 · 83 citations

Efficacy of perioperative immunonutrition in esophageal cancer patients undergoing esophagectomy

Shinsuke Kanekiyo, Shigeru Takeda, Michihisa Iida et al. · Nutrition · 2018 · 80 citations

Esophageal Cancer Patients, Esophagus, Esophageal Cancer +8